Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6231)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2021 (publication date) through Jun 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Farshidpour M, Ahmed M, Junna S, Merchant JL. Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review. World J Gastrointest Oncol 2021; 13(1): 1-11 [PMID: 33510845 DOI: 10.4251/wjgo.v13.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i1/1.htm |
| Number | Citing Articles |
| 1 |
Soo-Jeung Park, Da-eun Nam, Hae Chang Seong, Young S. Hahn. New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.842535
|
| 2 |
Chie Kudo-Saito, Narikazu Boku, Hidekazu Hirano, Hirokazu Shoji. Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1009701
|
| 3 |
Sukrit Mahajan, Mirko H. H. Schmidt, Ulrike Schumann. The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers 2023; 15(7): 2024 doi: 10.3390/cancers15072024
|
| 4 |
Junaid Arshad, Amith Rao, Matthew L. Repp, Rohit Rao, Clinton Wu, Juanita L. Merchant. Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences 2024; 25(5): 2985 doi: 10.3390/ijms25052985
|
| 5 |
Alain E. Andrea, Andrada Chiron, Sarah Mallah, Stéphanie Bessoles, Guillaume Sarrabayrouse, Salima Hacein-Bey-Abina. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.830292
|
| 6 |
Stella G. Hoft, Michelle D. Pherson, Richard J. DiPaolo. Discovering Immune-Mediated Mechanisms of Gastric Carcinogenesis Through Single-Cell RNA Sequencing. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.902017
|
| 7 |
Ayesha Zafar, Murtaza Hasan, Tuba Tariq, Zhifei Dai. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies. Bioconjugate Chemistry 2022; 33(6): 1011 doi: 10.1021/acs.bioconjchem.1c00437
|
| 8 |
Pawan Puri, Garfield Grimmett, Rawah Faraj, Laurielle Gibson, Ebony Gilbreath, Bradley K. Yoder. Elevated Protein Kinase A Activity in Stomach Mesenchyme Disrupts Mesenchymal-epithelial Crosstalk and Induces Preneoplasia. Cellular and Molecular Gastroenterology and Hepatology 2022; 14(3): 643 doi: 10.1016/j.jcmgh.2022.06.001
|
| 9 |
Valeria Lucarini, Daniela Nardozi, Valentina Angiolini, Monica Benvenuto, Chiara Focaccetti, Raffaele Carrano, Zein Mersini Besharat, Roberto Bei, Laura Masuelli. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. Biomedicines 2023; 11(6): 1761 doi: 10.3390/biomedicines11061761
|
| 10 |
Chikanori Tsutsumi, Kenoki Ohuchida, Naoki Katayama, Yutaka Yamada, Shoichi Nakamura, Sho Okuda, Yoshiki Otsubo, Chika Iwamoto, Nobuhiro Torata, Kohei Horioka, Koji Shindo, Yusuke Mizuuchi, Naoki Ikenaga, Kohei Nakata, Eishi Nagai, Takashi Morisaki, Yoshinao Oda, Masafumi Nakamura. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer. Gastric Cancer 2024; 27(2): 248 doi: 10.1007/s10120-023-01456-4
|
| 11 |
Qiqi Le, Chengyan Wang, Qi Shi, Yang Gao. Meta-Analysis on the Improvement of Symptoms and Prognosis of Gastrointestinal Tumors Based on Medical Care and Exercise Intervention. Journal of Healthcare Engineering 2021; 2021: 1 doi: 10.1155/2021/5407664
|